Design Therapeutics, Inc. (DSGN)

Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.09	22.56	21.2	26.5	298.57	2.38
Short-Term Investments	190.88	222.91	260.6	303.89	85.5	33.71
Cash & Short-Term Investments	205.97	245.48	281.8	330.39	384.06	36.09
Cash Growth	-18.93%	-12.89%	-14.71%	-13.98%	964.15%	46771.43%
Other Receivables	1.38	1.26	1.43	1.12	0.11	0.01
Receivables	1.38	1.26	1.43	1.12	0.11	0.01
Prepaid Expenses	1.68	1.3	1.35	3.62	1.26	0.06
Other Current Assets	-	-	-	-	-	0.07
Total Current Assets	209.03	248.04	284.58	335.12	385.44	36.23
Property, Plant & Equipment	2.74	3.63	4.63	5.56	5.12	0.07
Long-Term Deferred Charges	-	-	-	-	-	0.21
Other Long-Term Assets	-	0.43	0.43	0.46	-	-
Total Assets	211.77	252.09	289.64	341.14	390.56	36.52
Accounts Payable	1.91	2.19	1.94	3.03	1.62	1.4
Accrued Expenses	8.39	5.48	6.97	7.11	3.17	0.93
Current Portion of Leases	0.87	0.8	0.72	0.64	0.49	-
Total Current Liabilities	11.17	8.46	9.62	10.78	5.28	2.33
Long-Term Leases	0.88	1.53	2.33	3.05	3.14	-
Other Long-Term Liabilities	-	-	-	-	-	0.15
Total Liabilities	12.05	10	11.96	13.83	8.43	2.48
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	480.37	468.83	455.25	441.42	429.82	0.45
Retained Earnings	-281.01	-227.21	-177.63	-110.76	-47.46	-11.92
Comprehensive Income & Other	0.36	0.48	0.06	-3.36	-0.24	0.16
Total Common Equity	199.72	242.1	277.69	327.31	382.13	-11.32
Shareholders' Equity	199.72	242.1	277.69	327.31	382.13	34.04
Total Liabilities & Equity	211.77	252.09	289.64	341.14	390.56	36.52
Total Debt	1.74	2.33	3.05	3.69	3.63	-
Net Cash (Debt)	204.23	243.14	278.75	326.7	380.43	36.09
Net Cash Growth	-18.81%	-12.77%	-14.68%	-14.12%	954.09%	-
Net Cash Per Share	3.59	4.30	4.98	5.86	8.28	2.28
Filing Date Shares Outstanding	56.96	56.76	56.49	55.9	55.46	15.96
Total Common Shares Outstanding	56.96	56.75	56.47	55.9	55.44	15.96
Working Capital	197.86	239.58	274.96	324.34	380.15	33.9
Book Value Per Share	3.51	4.27	4.92	5.86	6.89	-0.71
Tangible Book Value	199.72	242.1	277.69	327.31	382.13	-11.32
Tangible Book Value Per Share	3.51	4.27	4.92	5.86	6.89	-0.71
Machinery	3.06	2.91	2.6	2.32	1.54	0.08
Construction In Progress	-	-	-	-	0.01	-
Leasehold Improvements	0.15	0.15	0.15	0.15	0.1	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q